Related Experiment Video

Updated: Mar 10, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.5K

Comparative analysis reveals amino acids critical for anticancer activity of peptide CIGB-552

Soledad Astrada1, Yolanda Gomez2, Exequiel Barrera3

  • 1Cell Biology Unit, Institut Pasteur de Montevideo, Mataojo 2020, 11400, Montevideo, Uruguay.

Journal of Peptide Science : an Official Publication of the European Peptide Society
|December 10, 2016
PubMed

Insights

The synthetic peptide CIGB-552 effectively reduces tumor size by interacting with COMMD1 protein. Its metabolites are less effective due to impaired cell penetration and reduced COMMD1 interaction, indicating the amino acid sequence is crucial for its antitumor activity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer cells develop resistance to existing anticancer drugs, necessitating the development of novel antitumor agents.
  • The synthetic peptide CIGB-552 has demonstrated efficacy in reducing tumor size and extending lifespan in preclinical models.
  • COMMD1 protein is identified as a key mediator of CIGB-552's antitumor effects, and CIGB-552 undergoes degradation into various metabolites in vivo.

Purpose of the Study:

  • To comparatively analyze the physicochemical properties, cellular internalization, and apoptosis-inducing capabilities of CIGB-552 and its main metabolites.
  • To investigate the cell-penetrating capacity and COMMD1 interaction of CIGB-552 metabolites.
  • To determine the structural features essential for CIGB-552's biological activity.

Main Methods:

  • Comparative analysis of physicochemical properties of CIGB-552 and its metabolites.
  • Assessment of cellular internalization in MCF-7 cells.
  • Evaluation of apoptosis induction in MCF-7 cells.
  • Analysis of metabolite-COMMD1 protein interaction.

Main Results:

  • None of the analyzed CIGB-552 metabolites exhibited the same efficacy as the parent peptide in promoting apoptosis in MCF-7 cells.
  • Cellular internalization, a process dependent on lipid binding, was impaired in the metabolites.
  • The interaction between metabolites and COMMD1 protein was significantly reduced compared to CIGB-552.

Conclusions:

  • The amino acid sequence of CIGB-552 is critical for its biological activity, defining it as the minimal functional unit.
  • Metabolites of CIGB-552 exhibit reduced antitumor efficacy due to impaired cell penetration and diminished interaction with COMMD1.
  • These findings highlight the importance of the intact peptide structure for effective anticancer activity.
Keywords:
COMMD1amino acidsapoptosiscell penetrating peptide

More Related Videos

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

2.0K
Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions10:26

Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions

Published on: December 20, 2017

10.0K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K